Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells

Advanced NSCLC patients harboring EML4-ALK and CCDC6-RET rearrangements derive benefit from treatment with ALK and RET TKIs but not immune checkpoint inhibitors. New immunotherapeutic approaches, such as immunization against growth factors, can be of particular interest for combination treatment in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Oncol
Egile Nagusiak: Codony-Servat, Jordi, García-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Viteri, Santiago, d'Hondt, Erik, Rosell, Rafael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7591385/
https://ncbi.nlm.nih.gov/pubmed/33129112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100887
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak